TruTrace Technologies Inc. (TTT.CN)
| Previous Close | 0.0750 |
| Open | 0.0750 |
| Bid | 0.0700 x N/A |
| Ask | 0.0800 x N/A |
| Day's Range | 0.0750 - 0.0800 |
| 52 Week Range | 0.0250 - 0.2550 |
| Volume | 11,812 |
| Avg. Volume | 137,652 |
| Market Cap | 6.669M |
| Beta (5Y Monthly) | 4.93 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0700 |
| Earnings Date | Aug. 23, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
MediPharm Labs Selected by University Health Network and Medical Cannabis by Shoppers Inc. for First Real-World Evidence, Patient-Centred Clinical Trial Using Blockchain Technology
TORONTO, July 16, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven.
- Yahoo Finance Canada
Shoppers Drug Mart aims to grow medical pot sales with more data
Shoppers Drug Mart is adding more robust data to its online medical cannabis marketplace to help doctors get comfortable prescribing the drug.
CNW GroupTruTrace Technologies and AdvancedCare announce strategic plan to integrate technology platforms
TORONTO, Oct. 16, 2019 /CNW/ - TruTrace Technologies Inc. (CSE: TTT) (OTCQB: TTTSF) ("TruTrace" or "the Company"), creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, and AdvancedCare, a leading clinical research, clinical and telemedicine platform used by medical professionals around the world, today announced that the two companies have entered into a letter of intent ("LOI") to begin a strategic working relationship to integrate their technologies to bring innovative solutions to the medical industry. Pursuant to the LOI, AdvancedCare plans to integrate TruTrace's StrainSecure™ technology within its own platform, with the objective of providing product data directly to medical professionals, patients and researchers to ensure medication has been verified and is safe to consume.
